Stocks › MDXG
MiMedx MDXG
US equityMarket cap rank #3671
$3.31 +$0.03 (+0.91%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $3.31 0.00%
Open$3.25
Prev close$3.28
Day range$3.23 – $3.39
Volume1.11M
Market cap$483.01M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$62.28M-45.2% YoY
Operating profit-$11.70M-152.7% YoY
Net profit-$8.68M-151.8% YoY
Diluted EPS-$0.06-154.5% YoY
Free cash flow-$1.14M-104.5% YoY
Operating cash flow$3.92M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin77.3%
Operating margin-8.3%
Net margin-6.3%
Return on equity-8.5%
Return on assets-6.6%
Return on invested capital-8.5%
Current ratio4.35
Liabilities / assets20.2%
Cash & investments$120.79M
Net cash (debt)$120.79M
Free cash flow / sales5.9%
Where the revenue comes from
Quarter 2026/Q2
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $62.28M | $64.36M | $58.99M | $418.63M | $118.10M |
| Total Operating Revenue | $62.28M | $64.36M | $58.99M | $418.63M | $118.10M |
| Cost of Revenue | $12.58M | $19.98M | $17.37M | $73.01M | $19.06M |
| Gross Profit | $49.70M | $44.38M | $41.62M | $345.62M | $99.04M |
| Operating Expense | $61.40M | $62.85M | $57.67M | $281.73M | $77.96M |
| Selling and Admin Expenses | $58.31M | $59.78M | $53.23M | $266.19M | $73.07M |
| -Selling & Marketing Expense | $39.60M | $46.42M | $43.91M | – | – |
| -General & Admin Expense | $18.71M | $13.36M | $9.32M | – | – |
| Research & Development | $2.80M | $2.78M | $4.14M | $15.10M | $4.76M |
| Depreciation & Amortization & Depletion | $295,000.00 | $291,000.00 | $301,000.00 | $439,000.00 | $129,000.00 |
| -Depreciation & Amortization | $295,000.00 | $291,000.00 | $301,000.00 | $439,000.00 | $129,000.00 |
| Operating Profit | -$11.70M | -$18.47M | -$16.05M | $63.89M | $21.08M |
| Net Non-Operating Interest Income (Expense) | $776,000.00 | $788,000.00 | $886,000.00 | $2.93M | $904,000.00 |
| Non-Operating Interest Income | $986,000.00 | – | $1.29M | – | – |
| Non-Operating Interest Expense | $210,000.00 | – | $402,000.00 | – | – |
| Other Income (Expense) | -$136,000.00 | -$102,000.00 | -$168,000.00 | -$558,000.00 | -$186,000.00 |
| Other Non-Operating Income (Expenses) | -$136,000.00 | -$102,000.00 | -$168,000.00 | -$558,000.00 | -$186,000.00 |
| Pretax Profit | -$11.06M | -$17.78M | -$15.33M | $66.26M | $21.80M |
| Tax | -$2.38M | -$2.94M | -$4.47M | $17.68M | $6.60M |
| Net Profit | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| Profit from Continuing Operations | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| Net Income to Parent Company | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| Net Income to Common Stockholders | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| Basic EPS | -$0.06 | -$0.10 | -$0.07 | $0.33 | $0.10 |
| Diluted EPS | -$0.06 | -$0.10 | -$0.07 | $0.32 | $0.10 |
| Total Other Finance Costs | – | -$788,000.00 | – | -$2.93M | – |
| Special Income (Charges) | – | – | – | $0.00 | $0.00 |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | $0.00 |
| Net Income from Discontinuous Operations | – | – | – | $0.00 | $0.00 |
| Other Preferred Stock Dividends | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $264.55M | $281.00M | $308.68M | $342.65M | $342.65M |
| Total Current Assets | $187.23M | $205.37M | $240.33M | $277.47M | $277.47M |
| Cash and Cash Equivalents & Short-Term Investments | $120.79M | $135.84M | $159.77M | $166.12M | $166.12M |
| -Cash and Cash Equivalents | $120.79M | $135.84M | $159.77M | $166.12M | $166.12M |
| Receivables | $37.27M | $41.30M | $46.03M | $75.71M | $75.71M |
| -Accounts Receivable | $37.27M | $41.30M | $46.03M | $75.71M | $75.71M |
| Inventory | $22.09M | $20.93M | $26.23M | $25.34M | $25.34M |
| Other Current Assets | $7.09M | $7.30M | $8.29M | $10.30M | $10.30M |
| Total Non-Current Assets | $77.32M | $75.63M | $68.35M | $65.18M | $65.18M |
| Net PPE | $4.71M | $4.91M | $4.76M | $4.71M | $4.71M |
| -Gross PPE | $29.35M | $29.21M | $28.62M | $28.21M | $28.21M |
| -Accumulated Depreciation | -$24.64M | -$24.30M | -$23.86M | -$23.50M | -$23.50M |
| Goodwill and Other Intangible Assets | $30.56M | $31.53M | $32.58M | $33.60M | $33.60M |
| -Goodwill | $19.44M | $19.44M | $19.44M | $19.44M | $19.44M |
| -Other Intangible Assets | $11.12M | $12.09M | $13.14M | $14.16M | $14.16M |
| Non-Current Deferred Assets | $29.22M | $27.30M | $24.13M | $19.60M | $19.60M |
| Other Non-Current Assets | $12.83M | $11.90M | $6.89M | $7.27M | $7.27M |
| Total Liabilities | $53.47M | $65.00M | $65.74M | $86.11M | $86.11M |
| Total Current Liabilities | $43.03M | $38.50M | $44.55M | $64.27M | $64.27M |
| Payables | $11.83M | $8.29M | $11.46M | $14.53M | $14.53M |
| -Accounts Payable | $11.83M | $8.29M | $11.46M | $14.53M | $14.53M |
| Current Accrued Expenses | $12.77M | $11.14M | $11.01M | $11.38M | $11.38M |
| Other Current Liabilities | $3.19M | $4.39M | $6.05M | $5.79M | $5.79M |
| Total Non-Current Liabilities | $10.44M | $26.50M | $21.19M | $21.84M | $21.84M |
| Other Non-Current Liabilities | $10.44M | $10.79M | $5.10M | $5.37M | $5.37M |
| Total Equity | $211.08M | $216.00M | $242.94M | $256.55M | $256.55M |
| Stockholders' Equity | $211.08M | $216.00M | $242.94M | $256.55M | $256.55M |
| Capital Stock | $149,000.00 | $149,000.00 | $149,000.00 | $148,000.00 | $148,000.00 |
| -Common Stock | $149,000.00 | $149,000.00 | $149,000.00 | $148,000.00 | $148,000.00 |
| Additional Paid-In Capital | $300.86M | $297.09M | $296.33M | $299.08M | $299.08M |
| Retained Earnings | -$77.06M | -$68.38M | -$53.54M | -$42.68M | -$42.68M |
| Less: Treasury Stock | $12.86M | $12.86M | – | – | – |
| Short-Term Debt and Capital Lease Obligation | – | $1.50M | $1.50M | $1.50M | $1.50M |
| -Current Debt | – | $1.50M | $1.50M | $1.50M | $1.50M |
| Long Term Debt and Capital Lease Obligation | – | $15.71M | $16.09M | $16.47M | $16.47M |
| -Long Term Debt | – | $15.71M | $16.09M | $16.47M | $16.47M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.92M | -$10.02M | $1.88M | $74.00M | $24.96M |
| Net cash flow from continuing operations | $3.92M | -$10.02M | $1.88M | $74.00M | $24.96M |
| Net Income from Continuing Operations | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| Depreciation & Depletion & Amortization | $1.46M | $1.53M | $1.62M | $14.88M | $3.22M |
| Deferred Tax | -$1.92M | -$3.17M | -$4.53M | $8.71M | $2.05M |
| Other Non-Cash Items | $362,000.00 | $438,000.00 | $448,000.00 | $1.90M | $423,000.00 |
| Change in Working Capital | $8.66M | -$160,000.00 | $15.44M | -$22.98M | -$1.76M |
| -Change in Receivables | $1.76M | -$545,000.00 | $28.21M | -$26.39M | -$887,000.00 |
| -Change in Inventory | -$1.16M | $5.30M | -$889,000.00 | -$1.53M | $1.16M |
| -Change in Payables and Accrued Expense | $7.76M | -$4.30M | -$14.15M | $13.48M | $388,000.00 |
| -Change in Other Current Assets | $453,000.00 | $1.27M | $2.01M | -$8.82M | -$3.89M |
| Net cash flow from investing | -$193,000.00 | -$635,000.00 | -$5.64M | -$6.89M | -$335,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$193,000.00 | -$635,000.00 | -$5.64M | -$6.89M | -$335,000.00 |
| Net PPE Purchase and Sale | -$166,000.00 | -$598,000.00 | -$570,000.00 | -$1.03M | -$285,000.00 |
| Net Intangibles Purchase and Sale | -$4.89M | – | – | – | – |
| Financing Cash Flow | -$18.77M | -$13.28M | -$2.59M | -$5.41M | -$583,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$18.77M | -$13.28M | -$2.59M | -$5.41M | -$583,000.00 |
| Net Issuance Payments Of Debt | -$17.25M | -$375,000.00 | -$375,000.00 | -$1.00M | -$250,000.00 |
| Net Common Stock Issuance | -$372,000.00 | -$12.60M | -$1.90M | -$3.12M | -$51,000.00 |
| Net Other Financing Charges | -$1.15M | -$314,000.00 | -$309,000.00 | -$1.29M | -$282,000.00 |
| Ending Cash Balance | $120.79M | $135.84M | $159.77M | $166.12M | $166.12M |
| Net Change in Cash | -$15.05M | -$23.93M | -$6.35M | $61.71M | $24.04M |
| Beginning Cash Balance | $135.84M | $159.77M | $166.12M | $104.42M | $142.08M |
| Free Cash Flow | -$1.14M | -$10.72M | $1.31M | $72.97M | $28.44M |
| Net Business Purchase and Sale | – | $0.00 | -$5.00M | -$3.76M | – |
| -Change In Other Working Capital | – | – | $250,000.00 | $289,000.00 | $1.47M |
| Net Other Investing Changes | – | – | -$72,000.00 | -$2.09M | -$50,000.00 |
| Cash Flow from Discontinued Operating Activities | – | – | – | $0.00 | $0.00 |
| Net Preferred Stock Issuance | – | – | – | $0.00 | – |
| Proceeds from Stock Option Exercised | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on MDXG.
Sign in to join the discussion.